Your Health. Your Family. Your Choice.
Life Threatening? No
Write-up: DRUG INEFFECTIVE; ASYMPTOMATIC COVID-19; This spontaneous report received from a health care professional via a Regulatory (EVHUMAN Vaccines, PT-INFARMED-B202109-620) on 23-SEP-2021 and concerned a 40 year old male. The patient''s height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 21C16-03 expiry: UNKNOWN) 0.5 ml, 1 total, administered on 26-AUG-2021 for covid-19 immunisation. Duration of drug administration 0 days. No concomitant medications were reported. On 04-SEP-2021, the patient had asymptomatic COVID-19 and experienced drug ineffective (Possible vaccine failure). Laboratory data included: SARS-CoV-2 RT-PCR test (NR: not provided) Positive Iu international unit (s). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the drug ineffective and asymptomatic covid-19 was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint.; Reporter''s Comments: Other information: RT PCR test positive on 04-Sep-2021; Asymptomatic
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166